Advanced Glycation Endproducts and Diabetes. Beyond Vascular Complications

E-ISSN： 2212-3873|11|2|132-140

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.11, Iss.2, 2011-06, pp. : 132-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End-products Enhance Calcification in Vascular Smooth Muscle Cells

By Ren X Shao H Wei Q Sun Z Liu N

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 847-854

Field House Publishing

Access to resources Recommend Favorite

Unchanged serum levels of advanced glycation endproducts in patients with liver disease

By Butscheid Moritz Schäfer Christian Brenner Stefanie Alscher Dominik Mürdter Thomas Niwa Toshimitsu Frischmann Matthias Pischetsrieder Monika Klotz Ulrich

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 6, 2007-08 ,pp. : 401-406

Springer Publishing Company

Access to resources Recommend Favorite

Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimer's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 249-266

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 973-978

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced glycation end products and diabetic complications

By Stitt Alan W Jenkins Alicia J Cooper Mark E

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1205-1223

Informa Healthcare

Access to resources Recommend Favorite